Bonnie S. Kimmel, MD
Endocrinologist, Principal Investigator
- Phone: 925-930-7267
- Email: bkimmel@diabloclinical.com
Experience:
2022-Present Investigator, Diablo Clinical Research
2009-2022 Endocrinologist, John Muir Medical Group
Drug and Device Phase I-IV Studies
Principal Investigator for 5+ studies and Sub-Investigator for 55+ studies which include:
Diabetes Device: Continuous Glucose Monitor, Glucometer/Blood Glucose Meter, Insulin Pump, Artificial Pancreas/Hybrid Closed Loop
Endocrine/Cardiovascular/Weight Loss: Diabetes Mellitus Types 1 and 2, Diabetic Peripheral Neuropathy, Hypercholesterolemia, Hypertension, Metabolic Syndrome, Obesity/Weight Loss, Dyslipidemia, Osteoporosis, Osteopenia,
Healthy Volunteer: Phase 1 Studies, Device studies (indications include diabetes, cardiovascular), Marketing/Usability Studies, Bioequivalence, Cosmetic Skin Studies, Nutrition Studies
Pain/Neuroscience: Diabetic Peripheral Neuropathy, Migraine
Vaccine: RSV, COVID-19, Flu, Shingles, CMV, HPV, Pneumococcal, eColi
Education:
2008-2009 Wilsey Advanced Diabetes Fellowship,
2007-2009 Fellowship in Endocrinology and Metabolism
University of California at San Francisco
2005-2006 Chief Resident
2002-2005 Internal Medicine Internship and Residency
Yale University Department of Internal Medicine,
1998-2002 Doctor of Medicine,
Brown University School of Medicine
1997-1998 Post-Baccalaureate Pre-Medical Program,
Bryn Mawr College
1991-1995 Bachelor of Arts with Honors, Human Biology,
Stanford University
Licensure:
Medical License State of California #A98500
Training:
Good Clinical Practice, 2022
Protecting Human Research Participants, 2022
Standard Operating Procedures for Diablo Clinical Research, Inc., 2023
C-SSRS Certified Since 2022
Memberships/Awards/Appointments:
Johnson and Johnson Physician Scholars Award, 2004
Endocrine Society
American Diabetes Association
Publications:
Bonnie Kimmel and Silvio Inzucchi. Oral Agents for Type 2 Diabetes: An Update. Clinical Diabetes. 2005; 23: 64-76.
